Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Sally Hansen continues to lead in innovation by introducing its new Color Therapy products: a nail polish, top coat, and nail & cuticle oil, inspired by women’s desire to wear beautiful color while simultaneously caring for their nails. Sally Hansen’s Color Therapy nail polish contains a patented micro-delivery system that delivers an argan oil-enriched formula, resulting in intensive nourishment and instant moisture for healthier-looking nails. The Color Therapy nail polish needs no base coat so the oil complex can directly contact the bare nail. 9 out of 10 women experienced a noticeable improvement in their natural nails after wearing the Color Therapy nail polish. Vibrant tones, available in three magnificent palettes, glide on for a radiant, shiny finish with up to 10 days of fade-proof, chip-resistant wear. The Color Therapy nail polish provides the ultimate color that cares while you wear, with everything needed to restore nails without sacrificing luminous color.
Complete your manicure with the Color Therapy top coat and nail & cuticle oil, both formulated with the same argan oil contained in the nail polish. The top coat provides an ultra-glossy finish for extended wear, and the nail & cuticle oil, the ultimate in nail therapy, instantly makes nails and cuticles look healthier, restored, and rejuvenated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7957151-sally-hansen-color-therapy-nail-polish/
Former Division I basketball player and all-pro tight end Tony Gonzalez is teaming up with CLEARMEN SCALP THERAPYTM to share his tips on executing The Perfect Play during March Madness this year.
From picking a winning bracket to hosting the perfect Final Four® party, Gonzalez, with the help of CLEAR MEN SCALP THERAPY™, has you covered. He helped the University of California-Berkeley reach the Sweet Sixteen® in the 1997 NCAA tournament, so he knows what it takes to win on the hardwood. Plus, with the Final Four in Atlanta this year, where Gonzalez has spent the last four pro football seasons, he can even help you throw the perfect Southern-inspired Finals party.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61089-tony-gonzalez-and-clear-men-scalp-therapy-the-perfect-play-march-madness
The face – and hair – of CLEAR SCALP & HAIR BEAUTY THERAPY™, Heidi Klum, rallied women at The Grove in Los Angeles, and across America, and invited them to join her and work at the right end of hair – the scalp. For years, women have been working at the ends of hair, rather than the foundation. Ninety-nine percent of hair’s natural strength and beauty comes from the scalp; CLEAR SCALP & HAIR BEAUTY THERAPY™ nourishes the scalp and creates the right foundation for strong, beautiful hair from root to tip. In an effort to spread the message of working at the right end of hair, CLEAR SCALP & HAIR BEAUTY THERAPY™ is calling attention to the “Right End” Hair Revolution – a movement that began last spring and is inspiring women to adopt a haircare regimen that starts with scalp nourishment.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61517-heidi-klum-clear-scalp-and-hair-beauty-therapy-right-end-hair-revolution
Visit www.thespiritconnect.com for more New Age Videos, Articles and Discussion on Meditation, Yoga, Astrology, Accupuncture, Qi-Gong.
Sound is a powerful, primitive force. For Centuries, healers have intuitively used the therepeautic powers of sound. In the native traditions of ancient cultures, examples of sound and vibration--as elemental in creation and to wholeness--abound. Many tools have been used since the beginning of time to create music, and to aid healing: planetary gongs and Tibetan bowls, didgeridoos, rattles and drums. Today, a growing number of modern practitioners are rediscovering sound as a tool for healing and realignment. More modern sound therapy tools are--tuning forks, chimes, resonator plates, sound discs, and sound tables. All play an important role in healing. Sound is that which is produced when some object is vibrating in a random or periodic repeated motion.
As the American Massage Therapy Association® (AMTA®) marks its 15th annual National Massage Therapy Awareness Week October 23 – October 29, 2011, more consumers are using massage therapy for pain relief and other health issues. In fact, according to a recent consumer survey commissioned by AMTA, consumers are progressively integrating massage therapy into their regular health maintenance routines.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52739-american-massage-therapy-association-amta-pain-relief-health-benefits
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K.
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
Pain can negatively affect a person’s quality of life and impede recovery from illness or injury. Recent research compiled by the American Massage Therapy Association (AMTA) suggests that massage can be a helpful pain management strategy for manually controlling symptoms in people suffering metastatic cancer and rheumatoid arthritis, among other illnesses, as well as post-cardiac surgery pain.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61665-amta-massage-therapy-for-pain-relief-cancer-arthritis-post-cardiac-surgery
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children’s Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64394-chop-penn-harness-engineered-t-cells-eliminate-tumors-in-blood-leukemia
